SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001564590-19-035125
Filing Date
2019-09-20
Accepted
2019-09-20 16:09:40
Documents
8
Effectiveness Date
2019-09-20

Document Format Files

Seq Description Document Type Size
1 S-8 arav-s8.htm S-8 148134
2 EX-5.1 arav-ex51_6.htm EX-5.1 10277
3 EX-23.1 arav-ex231_227.htm EX-23.1 3622
4 EX-23.2 arav-ex232_228.htm EX-23.2 2077
5 EX-99.1 arav-ex991_9.htm EX-99.1 271094
6 EX-99.2 arav-ex992_8.htm EX-99.2 88169
7 EX-99.3 arav-ex993_7.htm EX-99.3 39285
8 GRAPHIC g3j5gi0wk24v000001.jpg GRAPHIC 4459
  Complete submission text file 0001564590-19-035125.txt   570066
Mailing Address LYONDELLBASELL TOWER 1221 MCKINNEY STREET, SUITE 3200 HOUSTON TX 77010
Business Address LYONDELLBASELL TOWER 1221 MCKINNEY STREET, SUITE 3200 HOUSTON TX 77010 936-355-1910
Aravive, Inc. (Filer) CIK: 0001513818 (see all company filings)

IRS No.: 264106690 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-233866 | Film No.: 191104796
SIC: 2834 Pharmaceutical Preparations